Wimmer K, Hlauschek D, Balic M, Pfeiler G, Greil R, Singer C
Breast. 2025; 80:104415.
PMID: 39985843
PMC: 11904565.
DOI: 10.1016/j.breast.2025.104415.
Sperduto P, Salama A, Anders C
Neuro Oncol. 2023; 25(7):1321-1322.
PMID: 36883201
PMC: 10326485.
DOI: 10.1093/neuonc/noad050.
Liposits G, Skuladottir H, Ryg J, Winther S, Moller S, Hofsli E
J Clin Med. 2022; 11(19).
PMID: 36233472
PMC: 9571053.
DOI: 10.3390/jcm11195603.
Foko L, Narang G, Tamang S, Hawadak J, Jakhan J, Sharma A
Virulence. 2022; 13(1):634-653.
PMID: 36036460
PMC: 9427047.
DOI: 10.1080/21505594.2022.2056966.
Li B, Wang J, Liu F, Li R, Hu W, Etcheverry A
J Oncol. 2022; 2022:6345160.
PMID: 35712126
PMC: 9194959.
DOI: 10.1155/2022/6345160.
Experimental Nuclear Medicine Meets Tumor Biology.
Balber T, Tran L, Bencurova K, Raitanen J, Egger G, Mitterhauser M
Pharmaceuticals (Basel). 2022; 15(2).
PMID: 35215337
PMC: 8878163.
DOI: 10.3390/ph15020227.
Mastering Prognostic Tools: An Opportunity to Enhance Personalized Care and to Optimize Clinical Outcomes in Physical Therapy.
Tousignant-Laflamme Y, Houle C, Cook C, Naye F, Leblanc A, Decary S
Phys Ther. 2022; 102(5).
PMID: 35202464
PMC: 9155156.
DOI: 10.1093/ptj/pzac023.
Salvage therapy for prostate cancer after radical prostatectomy.
Zaorsky N, Calais J, Fanti S, Tilki D, Dorff T, Spratt D
Nat Rev Urol. 2021; 18(11):643-668.
PMID: 34363040
DOI: 10.1038/s41585-021-00497-7.
Predictive Factors for Outcomes of Overcorrection Nighttime Bracing in Adolescent Idiopathic Scoliosis: A Systematic Review.
Moradi V, Babaee T, Shariat A, Khosravi M, Saeedi M, Parent-Nichols J
Asian Spine J. 2021; 16(4):598-610.
PMID: 34304236
PMC: 9441430.
DOI: 10.31616/asj.2021.0037.
Heat Shock Factor 1 as a Prognostic and Diagnostic Biomarker of Gastric Cancer.
Kim W, Kim S
Biomedicines. 2021; 9(6).
PMID: 34064083
PMC: 8224319.
DOI: 10.3390/biomedicines9060586.
Genomics models in radiotherapy: From mechanistic to machine learning.
Kang J, Coates J, Strawderman R, Rosenstein B, Kerns S
Med Phys. 2020; 47(5):e203-e217.
PMID: 32418335
PMC: 8725063.
DOI: 10.1002/mp.13751.
Prognostic factors in the progression of intervertebral disc degeneration: Which patient should be targeted with regenerative therapies?.
Rustenburg C, Faraj S, Ket J, Emanuel K, Smit T
JOR Spine. 2019; 2(3):e1063.
PMID: 31572980
PMC: 6764790.
DOI: 10.1002/jsp2.1063.
The Use of (Network) Meta-Analysis in Clinical Oncology.
Ter Veer E, van Oijen M, van Laarhoven H
Front Oncol. 2019; 9:822.
PMID: 31508373
PMC: 6718703.
DOI: 10.3389/fonc.2019.00822.
Novel predictive epigenetic signature for temozolomide in non-G-CIMP glioblastomas.
Yin A, He Y, Etcheverry A, Liu Y, Aubry M, Barnholtz-Sloan J
Clin Epigenetics. 2019; 11(1):76.
PMID: 31088577
PMC: 6515684.
DOI: 10.1186/s13148-019-0670-9.
Prognostic and Predictive Factors for the Curative Treatment of Esophageal and Gastric Cancer in Randomized Controlled Trials: A Systematic Review and Meta-Analysis.
Ende T, Ter Veer E, Mali R, van Berge Henegouwen M, Hulshof M, van Oijen M
Cancers (Basel). 2019; 11(4).
PMID: 31013858
PMC: 6521055.
DOI: 10.3390/cancers11040530.
Predictive factors for brace treatment outcome in adolescent idiopathic scoliosis: a best-evidence synthesis.
Bogaart M, van Royen B, Haanstra T, de Kleuver M, Faraj S
Eur Spine J. 2019; 28(3):511-525.
PMID: 30607519
DOI: 10.1007/s00586-018-05870-6.
Prediction of non-muscle-invasive bladder cancer recurrence by measurement of checkpoint HLAG's receptor ILT2 on peripheral CD8 T cells.
Desgrandchamps F, LeMaoult J, Goujon A, Riviere A, Rivero-Juarez A, Djouadou M
Oncotarget. 2018; 9(69):33160-33169.
PMID: 30237859
PMC: 6145700.
DOI: 10.18632/oncotarget.26036.
Detecting long non-coding RNA biomarkers in prostate cancer liquid biopsies: Hype or hope?.
Helsmoortel H, Everaert C, Lumen N, Ost P, Vandesompele J
Noncoding RNA Res. 2018; 3(2):64-74.
PMID: 30159441
PMC: 6096408.
DOI: 10.1016/j.ncrna.2018.05.001.
Subgroups from regression trees with adjustment for prognostic effects and postselection inference.
Loh W, Man M, Wang S
Stat Med. 2018; 38(4):545-557.
PMID: 29671896
PMC: 7015042.
DOI: 10.1002/sim.7677.
The Clinical Significance of O-Methylguanine-DNA Methyltransferase Promoter Methylation Status in Adult Patients With Glioblastoma: A Meta-analysis.
Zhao Y, Wang Z, Cao C, Weng H, Xu C, Li K
Front Neurol. 2018; 9:127.
PMID: 29619003
PMC: 5873285.
DOI: 10.3389/fneur.2018.00127.
